MercachemSyncom, a leading mid-sized European drug-discovery contract research organization, has acquired Admescope Ltd. based in Oulu, Finland and Södertälje, Sweden.   The acquisition will give MercachemSyncom significantly expanded capabilities for tailor-made in vitro and in vivo ADME-Tox studies for pre-clinical and early clinical R&D projects and seamless integration with the existing medicinal, synthetic and development chemistry capabilities of MercachemSyncom. Admescope brings exper...